Katarina Huić Babić

Dr
Katarina
Huić Babić

Genera d.d. (Genera d.d. is a part of the Dechra Pharmaceuticals PLC Group)
Biography

Expert at Vaccines Development, Business Unit Vaccines at Dechra Pharmaceuticals PLC  - Development of new live attenuated and inactivated viral vaccines for veterinary use in accordance to cGMP and in compliance with Ph. Eur; Development, optimization and validation of molecular assays (PCR/ real-time PCR) for detection of extraneous agents in avian viral vaccines; Development, optimization and validation of PCR based assays for identification and differentiation of avian viruses; Laboratory animal studies

Research interests

Development of new live attenuated and inactivated viral vaccines for veterinary use

Development, optimization and validation of molecular assays (PCR/ real-time PCR) for quality control of avian viral vaccines

Molecular identification and characterization of avian viruses

Development and optimisation of biological assays

Laboratory animal studies

Discipline
Bacteriology Challenge model development Challenge study design Clinical trials – efficacy Clinical trials – safety QC test development Quality assurance Virology
Host species
Pigs Poultry
Pathogen
Bacteria Bacteria›Clostridia Bacteria›E. coli Bacteria›Salmonella Viruses Viruses›African swine fever virus Viruses›Avian papillomavirus Viruses›Avian polyomavirus Viruses›Chicken anaemia virus Viruses›Classical swine fever virus Viruses›Coronavirus Viruses›Infectious bursal disease virus Viruses›Influenza virus Viruses›Mareks disease virus Viruses›Newcastle disease virus Viruses›Porcine circovirus Viruses›Poxviruses
Stage of vaccine development
Antigen discovery and immunogen design Clinical trials Correlates of protection – immunomonitoring Field trials Pre-clinical trials Vaccine delivery